Next Article in Journal
The Impact of Extracorporeal Magnetic Stimulation as Addition to Mirabegron in Overactive Bladder Treatment in Women: A Single-Centre Randomized Sham-Controlled Study
Previous Article in Journal
Impact of the Order of Movement on the Median Nerve Root Function: A Neurophysiological Study with Implications for Neurodynamic Exercise Sequencing
Previous Article in Special Issue
Nightmares and Sleep Disturbances in Children with PTSD: A Polysomnographic and Actigraphy Approach Evaluation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 13
Issue 3
10.3390/jcm13030914
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Gender Difference in REM Sleep Behavior Disorder in Japanese Population: Polysomnography and Sleep Questionnaire Study

by
Mamiko Mano
*,
Atsuhiko Nomura
and
Ryujiro Sasanabe
Department of Sleep Medicine and Sleep Disorders Center, Aichi Medical University, Nagakute 480-1195, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(3), 914; https://doi.org/10.3390/jcm13030914
Submission received: 26 December 2023 / Revised: 30 January 2024 / Accepted: 1 February 2024 / Published: 5 February 2024
(This article belongs to the Special Issue Editorial Board Members’ Collection Series: Sleep and Neuropsychiatric Disorders)
Browse Figure
Versions Notes

Abstract

:
Rapid eye movement (REM) sleep behavior disorder (RBD) is generally common among males and is an established risk factor for neurodegenerative diseases. As the population ages, the prevalence of α-synucleinopathy (such as Parkinson’s disease) is increasing. Additionally, the number of female patients is increasing in Japan. Therefore, we aimed to clarify the clinical characteristics of RBD from the perspective of gender differences in the Japanese population. The proportion of male RBD patients (65.2%) was significantly higher than that of female patients (34.8%). Additionally, female patients (70.5 ± 8.2 years) were significantly older than male patients (67.9 ± 8.0 years, p < 0.05). The mean score on the RBD Screening Questionnaire was significantly higher in male patients than in female (8.6 ± 2.9 vs. 7.7 ± 3.1, p < 0.05), while the mean score on the Pittsburgh Sleep Quality Index was significantly higher in males (5.9 ± 3.8 vs. 7.2 ± 3.600, p < 0.001). The Self-rating Depression Scale in females was 41.7 ± 8.5, and they were more likely to show depressive tendencies than males. In polysomnography, higher rates of obstructive sleep apnea and longer duration of stage N1 sleep were detected in males. After adjusting for age, BMI, and polysomnographic parameters, we found that female RBD patients had significantly worse sleep quality and rates of depression compared to male patients.

1. Introduction

Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during REM sleep and abnormal behaviors occurring during REM sleep, often as dream enactments that can cause injury [1,2]. Diagnosis is based on clinical history and polysomnographic documentation of excessive electromyographic activity during REM sleep. RBD may occur alone as RBD or as secondary RBD when comorbid with other medical conditions, such as neurodegenerative diseases, narcolepsy, or psychiatric disorders. The median age of RBD onset is 49 years [3]. RBD in patients aged under 40 years is often associated with narcolepsy. RBD is a well-established risk factor for neurodegenerative diseases such as Parkinson’s disease (PD), Lewy body dementia, and multiple system atrophy [4,5,6]. Prospective studies have estimated that at least 40–65% of patients with RBD will eventually develop a defined neurodegenerative phenotype, especially α-synucleinopathy [7,8,9,10]. A recent study on Japanese patients with RBD reported that 88% of them met the diagnostic criteria for prodromal Parkinson’s disease [11]. PD patients with RBD have more severe symptoms of PD and faster progression than those without RBD [12]. Importantly, RBD is a highly specific marker of future α-synucleinopathy.
The prevalence of RBD in the general population is approximately 0.74–2.01% [13,14,15,16,17]. A male predominance in the presentation of RBD has often been reported with a higher prevalence of RBD in male patients. RBD is clinically more common in male patients. On the other hand, the prevalence of female RBD patients ranges between 13–53.6% of all patients with RBD [14,18,19,20,21].
Although epidemiological studies have reported an equal proportion of males and females with RBD [14,21], case studies often show a male predominance [18,19,20]. Gender differences in the prevalence of RBD may be due to differences in the results between epidemiological studies and case studies. Despite the various studies regarding gender differences in the prevalence of RBD in the general population, this difference remains debatable.
The frequency of RBD complications is not significantly different between male and female PD patients [22]. Furthermore, the neurodegenerative risk in female RBD patients appears to be similar to that in male RBD patients [23]. Despite this imbalance, gender differences of RBD patients are still underreported. Thus, there is a lack of clarity regarding gender differences. PD is more common in men in Europe and the US and it is more common in females in Japan. As the incidence of the disease increases with age, the number of patients is rapidly increasing as the Japanese population ages. Thus, country-specific effects on gender difference in PD may also be found in RBD, an important parameter of α-synucleinopathy prodromal symptoms.
Therefore, this study aimed to evaluate, in detail, the gender differences in Japanese RBD patients using sleep questionnaires (subjective indicators) and polysomnography (PSG) parameters (objective indicators), and to clarify the characteristics of female RBD patients in Japanese population.

2. Materials and Methods

2.1. Ethical Approval

The study complied with the principles of the Declaration of Helsinki. The Ethical Committee of Aichi Medical University Hospital approved the study protocol before the collection and analysis of patient data (approval number: 2023-060). Written informed consent was not obtained due to the retrospective nature of this study. Therefore, we disclosed the study protocol on the institutional website (www.aichi-med-u.ac.jp (accessed on 10 August 2023) and offered the potential participants the opportunity to opt out of the study.

2.2. Patients

We assessed the medical records of patients who had been primarily diagnosed with RBD using video nocturnal polysomnography (v-PSG) at the Department of Sleep Medicine of the Aichi Medical University Hospital from May 2013 to March 2022. A total of 19 patients were excluded: 6 patients aged  <40 years, 10 patients with PD, 2 patients with Lewy body dementia, and 1 patient with multiple system atrophy. Finally, 204 patients (male: n = 133, female: n = 71) participated in the study (Figure 1).

2.3. Sleep Questionnaires

At the first visit, all patients were administered several questionnaires. The Epworth Sleepiness Scale (ESS) questionnaire consists of eight self-rated items, each scored from 0 to 3, which measure a patient’s likelihood of daytime sleepiness in various commonly encountered situations (ESS ≥ 11: excessive daytime sleepiness) [24]. The Pittsburgh Sleep Quality Index (PSQI) comprises 19 self-assessment items that evaluate subjective sleep quality and disability over the preceding month. A higher PSQI score indicates poorer subjective sleep quality (PSQI ≥ 5.5: poor sleep quality) [25]. The Self-rating Depression Scale (SDS) was used to screen patients for the potential presence of depressive disorders. (SDS ≥ 40: depressive states) [26]. Finally, the REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) was used for the evaluation of RBD symptoms (RBDSQ ≥ 5: suspected RBD) [27].

2.4. Polysomnography

V-PSG was performed using an Alice 5 or 6 System (Respironics Inc., Murryville, PA, USA) and a PSG-1100 (Nihon Kohden Co., Tokyo, Japan). The following examinations were performed to continuously monitor biological variables: electroencephalography, bilateral electro-oculography, chin and anterior tibial electromyogramphy, electrocardiography, airflow measurement using a nasal thermistor, measurement of respiratory effort based on thoracic and abdominal movements, body position, snoring sound, and arterial oxygen saturation and a synchronized video system. We used the American Academy of Sleep Medicine (AASM) manual (version 2.6) to score sleep and associated events [14]. The characteristic polysomnographic finding of RBD is REM sleep without atonia (RWA). It is an elevation of motor tone during REM sleep as measured by electromyography (EMG) activity in the chin and/or limb leads. Formal polysomnographic criteria for RWA developed by the AASM require either of the following: sustained elevation of chin EMG activity during REM sleep (higher than 50% of the 30-s epoch duration compared with the minimum amplitude during non-REM sleep) or excessive bursts of transient muscle activity in the chin or limb EMG during REM sleep, defined by the presence of five (50%) or more mini-epochs (30-s epoch is divided into ten sequential 3-s mini-epochs), containing bursts of transient muscle activity. In RBD, excessive transient muscle activity bursts last 0.1 to 5.0 s and are at least four times as high in amplitude as the background EMG activity [28].

2.5. Diagnosis of RBD

According to the third edition of the International Classification of Sleep Disorders (ICSD-3), a diagnosis of RBD requires all the following [29]:
  • Repeated episodes of sleep-related vocalizations and/or complex motor behaviors.
  • These behaviors are documented by polysomnography to occur during REM sleep or, based on the clinical history of dream enactment, are presumed to occur during REM sleep.
  • Polysomnographic recording demonstrates REM sleep without atonia (RWA).
  • The sleep disturbance is not better explained by another sleep disorder, mental disorder, medication, or substance use.

2.6. Statistical Analysis

Comparisons were made between males and females in terms of baseline characteristics, questionnaires, and PSG parameters and were conducted using the Mann–Whitney U test. Fisher’s exact test was conducted for categorical variables. Logistic regression analyses were used to estimate the effects of gender on sleep quality and depression, after adjusting for the age, body mass index (BMI), apnea hypopnea index (AHI), and arousal index. The covariates were selected based on their established clinical relationships with gender difference in RBD. Odds ratios (ORs) are presented, along with the 95% confidence intervals (CIs). All comparisons were two-tailed, and a p value < 0.05 was considered statistically significant. All data were analyzed using the SPSS software program version 28 (Armonk, NY, USA: IBM Corp).

3. Results

Table 1 shows a comparison between the clinical characteristics of male and female patients with RBD. The proportion of male patients was significantly higher (65.2%) than that of female patients (34.8%). In addition, female patients (70.5 ± 8.2 years) were significantly older than male patients (67.9 ± 8.0 years). Male patients were also significantly larger than female patients, with bigger waist and neck circumferences and higher BMI.
Table 2 shows a comparison of the sleep questionnaire responses between male and female patients with RBD. The average PSQI score was significantly higher in female patients than in male patients (male vs. female: 5.9 ± 3.8 vs. 7.2 ± 3.6, p < 0.001). The average SDS score was also significantly higher in female patients than male patients (male vs. female: 38.0 ± 8.7 vs. 41.7 ± 8.5, p < 0.001). However, the average RBDSQ score was significantly higher in male patients than in female patients (male vs. female: 8.6 ± 2.9 vs. 7.7 ± 3.1, p < 0.05). There was no significant gender difference in ESS scores (male vs. female: 6.7 ± 4.1 vs. 6.5 ± 4.4, p = 0.63).
Table 3 shows a detailed comparison of the PSG findings between male and female patients with RBD. Regarding the evaluated PSG parameters, we found several differences between male and female RBD patients. There was no significant gender difference in wake time after onset (WASO) (97.3 ± 57.3 vs. 89.0 ± 57.0, p = 0.28). Stage N1 sleep time relative to total sleep time (TST; 48.8 ± 17.7 vs. 36.5 ± 18.2, p < 0.001) and stage N2 sleep time relative to TST (32.1 ± 16.4 vs. 45.4 ± 17.4, p < 0.001) showed significant gender difference. There was no significant gender difference in stage N3 time relative to TST, but it was higher in females than in males (0.4 ± 1.4 vs. 1.0 ± 2.9, p = 0.07). There were no significant differences in REM sleep time relative to TST between male and female patients (18.7 ± 7.7 vs. 17.1 ± 6.6, p = 0.17). There were no significant gender differences in sleep latency or REM sleep latency. Male patients also demonstrated a significantly higher apnea/hypopnea index (AHI; 15.1 ± 7.6 vs. 7.2 ± 7.9, p < 0.001) and arousal index (29.5 ± 16.3 vs. 22.3 ± 11.8, p < 0.05) than female patients. There were no significant differences in oxygen-related items (lowest SpO2, CT90) between male and female patients. Proportion of AHI ≥ 5/h was significantly higher in males than in females (68.4 vs. 44.4, p < 0.05). Periodic limb movement index (PLMI) was 20.2 ± 28.0. PLMI was significantly higher in females than in males (17.5 ± 26.3 vs. 25.4 ± 30.5, p < 0.05).
Table 4 shows the results of the logistic regression analysis for the associations between sleep quality and gender in RBD patients. Female patients were significantly associated with poorer sleep quality in all models, including the unadjusted model (OR = 2.24, 95% CI = 1.235–4.058, p < 0.05), in the model adjusted for age (Model 1; OR = 2.19, 95% CI = 1.203–4.001, p < 0.05), in the model adjusted for the variables in Model 1 and BMI (Model 2; OR = 2.10, 95% CI = 1.145–3.855, p < 0.05), in the model adjusted for the variables in Model 2 and the AHI (Model 3; OR = 2.12, 95% CI = 1.137–3.939, p < 0.05), and in the model adjusted for the variables in Model 3 and the arousal index (Model 4; OR = 2.03, 95% CI = 1.082–3.796, p < 0.001). Female patients were significantly associated with depression in all models, including the unadjusted model (OR = 1.99, 95% CI = 1.109–3.575, p < 0.05), in the model adjusted for age (Model 1; OR = 2.06, 95% CI = 1.135–3.724, p < 0.05), in the model adjusted for the variables in Model 1 and BMI (Model 2; OR = 2.16, 95% CI = 1.178–3.954, p < 0.05), in the model adjusted for the variables in Model 2 and the AHI (Model 3; OR = 2.38, 95% CI = 1.276–4.437, p < 0.001, and in the model adjusted for the variables in Model 3 and the arousal index (Model 4; OR = 2.34, 95% CI = 1.251–4.371, p < 0.001).

4. Discussion

To our knowledge, this is the first report demonstrating gender differences using PSG parameters and sleep questionnaires in Japanese RBD patients. In this study of patients with RBD, females were significantly older than males at the time of diagnosis, which was consistent with the findings reported by Noboru et al. [23]. The prevalence of RBD is approximately 0.74–2.01% in the general population and approximately 2% in older adults [13,14,15,16]. In our study, the proportion of male patients with RBD was significantly higher (65.2%) than that of female patients (34.8%). Our results are similar to previous reports showing that RBD is a male-dominated parasomnia, with the prevalence in women we observed reporting a prevalence ranging from 13 to 36.5%. This was consistent with previous clinical studies [18,19,20]. Due to the relatively large sample size in our study, the prevalence of female RBD patients may have been distributed more highly among previous clinical case studies. However, our findings were inconsistent with the results of a recent epidemiological study that reported no gender differences in the prevalence of RBD [14,21]. As previously reported, our study is not an epidemiological study, so our study’s finding that RBD is male predominant may be due to sample size effects.
The RBDSQ is a sleep questionnaire for RBD with high sensitivity and specificity, and it is useful as a screening test [27]. In this study, the average score of the RBDSQ was 8.3 ± 3.0, which exceeded the cut-off value. However, female patients with RBD had significantly lower RBDSQ scores compared to male patients. A previous study found that male patients with RBD had a higher proportion of violent dreams and behaviors during sleep [22,30]. The higher RBDSQ scores could reflect the higher rates of violent behavior. In other words, female patients with RBD may have fewer aggressive dreams and behaviors than male patients with RBD, and it appears that clinical history or RBDSQ alone are not as sensitive in diagnosing female patients with RBD, which could lead to their condition being underdiagnosed. Therefore, the prevalence of the observed male predominance in RBD may be biased in clinical studies, because male RBD patients are more likely to exhibit significant motor events and are more likely to seek help in a medical center. There may be more subclinical symptoms among female patients with RBD. Hence, clarifying gender differences in clinical, subjective (sleep questionnaires), and objective (v-PSG) characteristics among patients with RBD is very important.
Previous studies have estimated that at least 40–65% of patients with RBD will eventually develop α-synucleinopathy. Therefore, RBD is a specific marker of future α-synucleinopathy [7,8,9,10]. The comorbidity of sleep disorders (hypersomnia, insomnia, restless legs syndrome (RLS), circadian rhythm dysfunction etc.) in α-synucleinopathy has been reported many times in the past [31]. However, sleep disturbances in patients with RBD have not received significant attention. In our study, the average ESS score in patients with RBD was 6.6, with no significant difference between males and females. Neither male nor female RBD patients exhibited excessive daytime sleepiness. However, the average PSQI score was 6.3 in RBD patients, indicating poor sleep quality, and this score was significantly higher in female patients compared to male patients. Taken together, our results indicate that subjective sleep problems in patients with RBD are related to poor sleep quality rather than to drowsiness, which was more pronounced in females.
Of the patients with RBD, 48.0% had a score of 40 or higher on the SDS, which is indicative of depression; the average SDS score was 39.2 in RBD patients. Female patients with RBD had mild depressive tendencies, with an average SDS score equal or above 40, and significantly higher than that of male patients. Previous studies have shown that 30% of patients with RBD have comorbid depression [31], supporting our finding of high rates of depressive tendencies. Previous studies have reported that depression increases the risk of subsequent PD diagnosis [32]. Therefore, female RBD patients with higher SDS may be at greater risk of progression to neurodegenerative diseases than males.
PSG results in our study showed that 60.3% of RBD patients had comorbid obstructive sleep apnea (OSA). Among patients with RBD, 34–61% have comorbid OSA [33,34,35]; thus, our estimated comorbidity (60.3%) is comparable to those reported in previous studies. Therefore, comorbid OSA is common in patients with RBD. Regarding PSG parameters, patients with RBD demonstrated an AHI of 12.4 per hour, indicating mild OSA. AHI was significantly higher in male than in female patients. The arousal index was also significantly higher in males. However, there was no significant difference between male and female patients with RBD regarding hypoxic burden. This may reflect the protective role conferred by the maintenance of muscle tone during REM sleep. In this study, RBD patients had higher WASO and longer REM latency. There was no difference from the findings presented in past reports [36,37]. Previous reports have not addressed gender differences in sleep architecture in terms of PSG parameters [37]. In our study, objective sleep quality, stage N2 and N3, was significantly lower in males than in females. In contrast, male patients spent more time in stage 1 sleep than female patients did. Objective sleep quality measured using PSG parameters was comparable to that shown in previous results [38]. This difference in objective sleep quality is thought to be related to the gender difference in OSA complication rate.
Depression is commonly reported in patients with OSA [39]. In our study, 48.0% of RBD patients showed a tendency toward depression. RBD with OSA may make patients more prone to depression. Furthermore, in contrast to past studies [35,36], PLMI of female RBD patients was significantly higher than that in male patients in this study. Approximately 80% of restless legs syndrome (RLS) patients exhibit periodic limb movements in sleep. Patients with PD have a high incidence of RLS. It occurs more frequently in females [40]. Therefore, higher PLMI in female RBD patients may be associated with risk factors for progression to neurodegeneration.
To investigate gender differences in sleep quality and depression considering the effects of OSA, we selected age, BMI, AHI, and arousal index as model covariates in the logistic regression analysis since these characteristics have established differential clinical relationships with male and female patients with RBD. The results showed that female RBD patients had poor sleep quality (OR: 2.03–2.24) and higher risk of depression (OR: 1.99–2.34), indicating that they had worse sleep quality than male patients. We found that female patients with RBD suffered more from poor sleep quality and depression than male patients, regardless of the severity of apnea or wakefulness.
Patients with RBD are likely to inflict injuries on their bed partners by aggressive nightmares [41], and the psychological impact and burden in these patients are considerable. Previous research has shown that these patients are more likely to experience depression. In our study, the proportion of patients showing depression was high and tended to be higher among females than males. Therefore, female patients with RBD may experience greater psychological impacts and burdens. Since psychological impacts and burden can reduce sleep quality and increase rates of depression in patients with RBD, poor sleep quality and depression (rather than nightmares) may be the chief complaint in female patients with RBD. Considering that the neurodegenerative risk in female RBD patients is similar to that in male RBD patients, it is recommended to consider a gender perspective when diagnosing RBD.

Limitations

Our study had several limitations. First, a selection bias was present because the study was conducted at a single center in Japan. Second, we enrolled patients who visited the outpatient clinic with symptoms or were referred by other doctors for suspected RBD. Thus, asymptomatic patients and those with atypical symptoms were excluded. Third, because this was a retrospective study, gender differences in the risk of developing neurological diseases were not investigated.

5. Conclusions

The proportion of gender differences in RBD remains unclear. Therefore, female patients with RBD may be underdiagnosed. Female RBD patients had lower RBDSQ than males. Furthermore, contrary to the proportion of stages N2 and N3 in PSG parameters, subjective sleep quality was lower in females than in males. Furthermore, it was confirmed that female RBD patients were more likely to show a tendency toward depression. Until now, insufficient attention has been paid to the influence of RBD on sleep quality and depressive symptoms. It is particularly important to pay attention to sleep quality and depressive symptoms in female patients with RBD.

Author Contributions

Conceptualization: M.M. Methodology: M.M. Validation: A.N. Formal analysis: M.M. and R.S. Investigation: M.M. and R.S. Resources: A.N. Writing, original draft preparation: M.M. Writing, review and editing: M.M. Supervision: M.M. and R.S. Project administration: M.M. and R.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Aichi Medical University Hospital (approval number: 2023-060 and date of approval: 8 August 2023).

Informed Consent Statement

Written informed consent was not obtained due to the retrospective nature of the study. Therefore, we disclosed the study protocol was disclosed on the institutional website, and potential participants were offered the opportunity to opt out of the study.

Data Availability Statement

Data are contained within the article.

Acknowledgments

The authors wish to thank the patients whose clinical records were included in this study and the sleep technicians who manually scored the PSG data, including Riri Shioda, Takahito Imai, Takehiro Yamaguchi, Chihiro Kato, and Masato Imai.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Schenck, C.H.; Hurwitz, T.D.; Mahowald, M.W. Symposium: Normal and abnormal REM sleep regulation: REM sleep behaviour disorder: An update on a series of 96 patients and a review of the world literature. J. Sleep Res. 1993, 2, 224–231. [Google Scholar] [CrossRef]
  2. Schenck, C.H.; Mahowald, M.W. REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002, 25, 120–138. [Google Scholar] [CrossRef]
  3. Claassen, D.; Josephs, K.; Ahlskog, J.; Silber, M.H.; Tippmann-Peikert, M.; Boeve, B.F. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010, 75, 494–499. [Google Scholar] [CrossRef] [PubMed]
  4. Gagnon, J.F.; Postuma, R.B.; Mazza, S.; Doyon, J.; Montplaisir, J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol. 2006, 5, 424–432. [Google Scholar] [CrossRef] [PubMed]
  5. Boeve, B.F.; Silber, M.H.; Saper, C.B.; Ferman, T.J.; Dickson, D.W.; Parisi, J.E.; Benarroch, E.E.; Ahlskog, J.E.; Smith, G.E.; Caselli, R.C.; et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007, 130, 2770–2788. [Google Scholar] [CrossRef] [PubMed]
  6. Postuma, R.B.; Iranzo, A.; Hu, M.; Högl, B.; Boeve, B.F.; Manni, R.; Oertel, W.H.; Arnulf, I.; Ferini-Strambi, L.; Puligheddu, M.; et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: A multicentre study. Brain 2019, 142, 744–759. [Google Scholar] [CrossRef] [PubMed]
  7. Schenck, C.; Bundlie, S.; Mahowald, M. REM sleep behaviour disorder (RBD) delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the maximum and minimum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep 2003, 26, A316. [Google Scholar]
  8. Tippman-Peikert, M.; Olson, E.J.; Boeve, B.; Silber, M.H. Idiopathic REM sleep behavior disorder: A follow-up of 39 patients. Sleep 2006, 29, A272. [Google Scholar]
  9. Iranzo, A.; Molinuevo, J.; Santamaria, J.; Serradell, M.; Marti, M.; Valledeoriola, F. Sixty-four percent of patients with idiopathic REM sleep behavior disorder developed a neurological disorder after a mean clinical follow-up of seven years. Sleep 2008, 31, A280. [Google Scholar]
  10. Postuma, R.B.; Gagnon, J.F.; Vendette, M.; Fantini, M.L.; Massicotte-Marquez, J.; Montplaisir, J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009, 72, 1296–1300. [Google Scholar] [CrossRef]
  11. Nishikawa, N.; Murata, M.; Hatano, T.; Mukai, Y.; Saitoh, Y.; Sakamoto, T.; Hanakawa, T.; Kamei, Y.; Tachimori, H.; Hatano, K.; et al. Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study. Park. Relat. Disord. 2022, 103, 129–135. [Google Scholar] [CrossRef] [PubMed]
  12. Liu, Y.; Lawton, M.A.; Lo, C.; Bowring, F.; Klein, J.C.; Querejeta-Coma, A.; Scotton, S.; Welch, J.; Rassaque, J.; Barber, T.; et al. Longitudinal changes in Parkinson’s disease symptoms with and without rapid eye movement sleep behavior disorder: The oxford discovery cohort study. Mov. Disord. 2021, 36, 2821–2832. [Google Scholar] [CrossRef] [PubMed]
  13. Kang, S.H.; Yoon, I.Y.; Lee, S.D.; Han, J.W.; Kim, T.H.; Kim, K.W. REM sleep behavior disorder in the Korean elderly population: Prevalence and clinical characteristics. Sleep 2013, 36, 1147–1152. [Google Scholar] [CrossRef] [PubMed]
  14. Haba-Rubio, J.; Frauscher, B.; Marques-Vidal, P.; Toriel, J.; Tobback, N.; Andries, D.; Preisig, M.; Vollenweider, P.; Postuma, R.; Heinzer, R. Prevalence and determinants of REM sleep behavior disorder in the general population. Sleep 2017, 41, zsx197. [Google Scholar] [CrossRef]
  15. Pujol, M.; Pujol, J.; Alonso, T.; Fuentes, A.; Pallerola, M.; Freixenet, J.; Barbé, F.; Salamero, M.; Santamaría, J.; Iranzo, A. Idiopathic REM sleep behavior disorder in the elderly Spanish community: A primary care center study with a two-stage design using video-polysomnography. Sleep Med. 2017, 40, 116–121. [Google Scholar] [CrossRef] [PubMed]
  16. Sasai-Sakuma, T.; Takeuchi, N.; Asai, Y.; Inoue, Y.; Inoue, Y. Prevalence and clinical characteristics of REM sleep behavior disorder in Japanese elderly people. Sleep 2020, 43, zsaa024. [Google Scholar] [CrossRef]
  17. Lee, W.-J.; Baek, S.-H.; Im, H.-J.; Lee, S.-K.; Yoon, J.-E.; Thomas, R.J.; Wing, Y.-K.; Shin, C.; Yun, C.-H. REM sleep behavior disorder and its possible prodromes in general population: Prevalence, polysomnography findings, and associated factors. Neurology 2023, 101, e2364–e2375. [Google Scholar] [CrossRef]
  18. Olson, E.J.; Boeve, B.F.; Silber, M.H. Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases. Brain 2000, 123, 331–339. [Google Scholar] [CrossRef]
  19. Wing, Y.K.; Lam, S.P.; Li, S.X.; Yu, M.W.; Fong, S.Y.; Tsoh, J.M.; Ho, C.K.; Lam, V.K. REM sleep behavior disorder in Hong Kong Chinese: Clinical outcome and gender comparison. J. Neurol. Neurosurg. Psychiatry 2008, 79, 1415–1416. [Google Scholar] [CrossRef]
  20. Fernández-Arcos, A.; Iranzo, A.; Serradell, M.; Gaig, C.; Santamaria, I. The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients. Sleep 2016, 39, 121–132. [Google Scholar] [CrossRef]
  21. Wong, J.C.; Li, J.; Pavlova, M.; Chen, S.; Wu, A.; Wu, S.; Gao, X. Risk factors for probable REM sleep behavior disorder: A community-based study. Neurology 2016, 86, 1306–1312. [Google Scholar] [CrossRef]
  22. Bjørnara, K.A.; Dietrichs, E.; Toft, M. REM sleep behavior disorder in Parkinson’s disease—Is there a gender difference? Park. Relat. Disord. 2013, 19, 120–122. [Google Scholar] [CrossRef]
  23. Takeuchi, N.; Sasai-Sakuma, T.; Inoue, Y. Gender differences in clinical findings and a-synucleiopathy-related markers in patients with idiopathic REM sleep behavior disorder. Sleep Med. 2020, 66, 216–219. [Google Scholar] [CrossRef]
  24. Johns, M.W. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991, 14, 540–545. [Google Scholar] [CrossRef]
  25. Buysse, D.J.; Reynolds, C.F.; Monk, T.H.; Berman, S.R.; Kupfer, D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28, 193–213. [Google Scholar] [CrossRef] [PubMed]
  26. Zung, W.W.K. A self-rating depression scale. Arch. Gen. Psychiatry 1965, 12, 63–70. [Google Scholar] [CrossRef] [PubMed]
  27. Stiasny-Kolster, K.; Mayer, G.; Schäfer, S.; Möller, J.C.; Heinzel-Gutenbrunner, M.; Oertel, W.H. The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument. Mov. Disord. 2007, 22, 2386–2393, (RBDSQ). [Google Scholar] [CrossRef] [PubMed]
  28. Berry, R.B.; Budhiraja, R.; Gottlieb, D.J.; Gozal, D.; Iber, C.; Kapur, V.K.; Tangredi, M.M. Rules for scoring respiratory events in sleep: Update of the 2007 AASM manual for the scoring of sleep and associated events. J. Clin. Sleep Med. 2012, 8, 597–619. [Google Scholar] [CrossRef] [PubMed]
  29. Sateia, M.J. International Classification of Sleep Disorders, 3rd ed.; ICSD-3; American Academy of Sleep Medicine: Darien, CT, USA, 2014. [Google Scholar]
  30. Stanton, B.; Baldwin, R.M.; Rachuba, L. A quarter century of violence in the United States. An epidemiologic assessment. Psychiatr. Clin. N. Am. 1997, 20, 269–282. [Google Scholar] [CrossRef] [PubMed]
  31. Sumi, Y.; Masuda, F.; Kadotani, H.; Ozeki, Y. The prevalence of depression in isolated/idiopathic rapid eye movement sleep behavior disorder: A systematic review and meta-analysis. Sleep Med. Rev. 2022, 65, 101684. [Google Scholar] [CrossRef] [PubMed]
  32. Wang, S.; Mao, S.; Xiang, D.; Fang, C. Association between depression and the subsequent risk of Parkinson’s disease: A meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2018, 86, 186–192. [Google Scholar] [CrossRef]
  33. Boot, B.P.; Boeve, B.F.; Roberts, R.O.; Ferman, T.J.; Geda, Y.E.; Pankratz, V.S.; Ivnik, R.J.; Smith, G.E.; McDade, E.; Christianson, T.J.; et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population-based study. Ann. Neurol. 2012, 71, 49–56. [Google Scholar] [CrossRef]
  34. Zhang, J.; Li, S.X.; Lam, S.P.; Wing, Y.K. REM sleep behavior disorder and obstructive sleep apnea: Does one “evil” make the other less or more “evil”? Sleep Med. 2017, 37, 216–217. [Google Scholar] [CrossRef]
  35. Lee, S.A.; Paek, J.H.; Han, S.H.; Ryu, H.U. The utility of a Korean version of the REM sleep behavior disorder screening questionnaire in patients with obstructive sleep apnea. J. Neurol. Sci. 2015, 358, 328–332. [Google Scholar] [CrossRef] [PubMed]
  36. Sasai-Sakuma, T.; Kayaba, M.; Inoue, Y.; Nakayama, H. Prevalence, clinical symptoms and polysomnographic findings of REM-related sleep disordered breathing in Japanese population. Sleep Med. 2021, 80, 52–56. [Google Scholar] [CrossRef] [PubMed]
  37. Bugalho, P.; Salavisa, M. Factors influencing the presentation of REM sleep behavior disorder: The relative importance of sex, associated neurological disorder, and context of referral to polysomnography. J. Clin. Sleep Med. 2019, 15, 1789–1798. [Google Scholar] [CrossRef] [PubMed]
  38. Zhou, J.; Zhang, J.; Li, Y.; Du, L.; Li, Z.; Lei, F.; Wing, Y.; Kushida, C.; Zhou, D.; Tang, X. Gender differences in REM sleep behavior disorder: A clinical and polysomnographic study in China. Sleep Med. 2015, 16, 414–418. [Google Scholar] [CrossRef]
  39. Peppard, P.; Szklo-Coxe, M.; Mae Hla, K.; Young, T. Longitudinal association of sleep-related breathing disorder and depression. Arch. Intern. Med. 2006, 166, 1709–17915. [Google Scholar] [CrossRef]
  40. Zarranz, J.; Tijero, B.; Velasco, F.; Barcena, J.; Rouco, I.; Lezcano, E.; Lachen, M.; Jauregui, A.; Ugarte, A. Restless legs syndrome in Parkinson’s disease. Mov. Disord. 2007, 22, 1912–1916. [Google Scholar] [CrossRef]
  41. McCarter, S.J.; St Louis, E.K.; Boswell, C.L.; Dueffert, L.G.; Slocumb, N.; Boeve, B.F.; Silber, M.H.; Olson, E.J.; Morgenthaler, T.I.; Tippmann-Peikert, M. Factors associated with injury in REM sleep behavior disorder. Sleep Med. 2014, 15, 1332–1338. [Google Scholar] [CrossRef]
Jcm 13 00914 g001
Figure 1. Flowchart of patient inclusion. PSG: polysomnography; RBD: Rapid eye movement (REM) sleep behavior disorder.
Figure 1. Flowchart of patient inclusion. PSG: polysomnography; RBD: Rapid eye movement (REM) sleep behavior disorder.
Jcm 13 00914 g001
Table 1. Baseline characteristics of the enrolled patients with RBD.
Table 1. Baseline characteristics of the enrolled patients with RBD.
CharacteristicTotal
(n = 204)		Male
(n = 133)		Female
(n = 71)		p Value
Age (years)68.8 ± 8.167.9 ± 8.070.5 ± 8.2<0.05
BMI (kg/mm2)23.1 ± 2.923.5 ± 2.722.5 ± 3.3<0.05
Waist circumference (cm)87.4 ± 9.688.7 ± 9.484.9 ± 3.3<0.05
Neck circumference (cm)36.2 ± 4.938.0 ± 4.832.7 ± 2.4<0.001
Current Smoking (%)17.221.29.9<0.05
Alcohol intake (%)32.839.221.2<0.05
Table 2. Comparison of sleep questionnaires between male and female patients with RBD.
Table 2. Comparison of sleep questionnaires between male and female patients with RBD.
QuestionnaireTotal
(n = 204)		Male
(n = 133)		Female
(n = 71)		p Value
ESS6.6 ± 4.26.7 ± 4.16.5 ± 4.40.63
PSQI6.3 ± 3.85.9 ± 3.87.2 ± 3.6<0.001
PSQI ≥ 5.552.0 (%)45.1 (%)64.8 (%)<0.05
RBDSQ8.3 ± 3.08.6 ± 2.97.7 ± 3.1<0.05
SDS39.2 ± 8.838.0 ± 8.741.7 ± 8.5<0.001
SDS ≥ 4048.0 (%)41.4 (%)59.2 (%)<0.05
ESS: Epworth Sleep Scale; PSQI: Pittsburgh Sleep Quality Index; RBDSQ: REM Sleep Behavior Disorder Screening Questionnaire; SDS: Self-rating Depression Scale.
Table 3. Baseline characteristics and polysomnographic parameters of male and female patients with RBD.
Table 3. Baseline characteristics and polysomnographic parameters of male and female patients with RBD.
PSG ParameterTotal
(n = 204)		Male
(n = 133)		Female
(n = 71)		p Value
Time In Bed (min)485.4 ± 32.6485.4 ± 34.0485.2 ± 29.90.79
Total Sleep Time (min)365.5 ± 64.9363.9 ± 66.5368.4 ± 62.10.79
WASO (min)94.5 ± 57.297.3 ± 57.389.0 ± 57.00.28
Sleep Efficiency (%)75.4 ± 13.275.1 ± 13.376.2 ± 13.10.58
Sleep Latency (min)17.2 ± 19.216.7 ± 20.818.27 ± 16.20.71
REM Sleep Latency (min)145.4 ± 88.7133.5 ± 87.7167.6 ± 86.90.55
REM sleep time/TST (%)18.1 ± 7.318.7 ± 7.717.1 ± 6.60.17
Stage N1 sleep time/TST (%)44.6 ± 18.848.8 ± 17.736.5 ± 18.2<0.001
Stage N2 sleep time/TST (%)36.7 ± 17.932.1 ± 16.445.4 ± 17.4<0.001
Stage N3 sleep time/TST (%)0.6 ± 2.10.4 ± 1.41.0 ± 2.90.07
AHI (events/h)12.4 ± 15.415.1 ± 17.67.2 ± 7.9<0.001
AI (events/h)3.8 ± 9.25.4 ± 11.00.7 ± 1.8<0.001
HI (events/h)8.6 ± 9.29.7 ± 10.06.5 ± 7.0<0.05
3%ODI (events/h)9.6 ± 13.911.7 ± 15.85.8 ± 7.9<0.05
Arousal index (events/h)27.0 ± 15.329.5 ± 16.322.3 ± 11.8<0.001
Lowest SpO2 (%)89.9 ± 5.289.6 ± 5.490.5 ± 4.80.23
CT90 (%)0.76 ± 3.30.98 ± 3.90.36 ± 1.50.19
NREM-AHI (events/h)12.6 ± 15.915.5 ± 18.17.1 ± 7.7<0.001
REM-AHI (events/h)11.1 ± 16.313.0 ± 17.47.8 ± 13.7<0.05
SUP-AHI (events/h)16.7 ± 19.520.8 ± 21.99.0 ± 10.1<0.001
NSUP-AHI (events/h)4.3 ± 10.05.4 ± 11.92.1 ± 3.50.25
Proportion of AHI ≥ 5 (events/h) (%)60.368.444.4<0.05
Periodic limb movement index (events/h)20.2 ± 28.017.5 ± 26.325.4 ± 30.5<0.05
REM: random eye movement; TST: total sleep time; AHI: apnea hypopnea index; AI: apnea index; HI: hypopnea index; ODI: oxygen desaturation index; SpO2: peripheral capillary oxygen saturation index; CT90: cumulative percentage of time spent at oxygen saturation below 90%; SUP-AHI: AHI in supine position; NSUP-AHI: AHI in non-supine position.
Table 4. Associations between sleep quality and gender in patients with RBD.
Table 4. Associations between sleep quality and gender in patients with RBD.
ModelOR95% CIp Value
sleep qualityunadjusted2.241.235–4.058<0.05
Model 12.191.230–4.001<0.05
Model 22.101.145–3.855<0.05
Model 32.121.137–3.939<0.05
Model 42.031.082–3.796<0.001
depressionunadjusted1.991.109–3.575<0.05
Model 12.061.135–3.724<0.05
Model 22.161.178–3.954<0.05
Model 32.381.276–4.437<0.001
Model 42.341.251–4.371<0.001
Model 1: adjusted for age. Model 2: adjusted for the parameters in Model 1 + BMI. Model 3: adjusted for the parameters in Model 2 + AHI. Model 4: adjusted for the parameters in Model 3 + ArI. BMI: body mass index; AHI: apnea-hypopnea index; ArI: arousal index; OR: odds ratio; CI: confidence interval.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mano, M.; Nomura, A.; Sasanabe, R. Gender Difference in REM Sleep Behavior Disorder in Japanese Population: Polysomnography and Sleep Questionnaire Study. J. Clin. Med. 2024, 13, 914. https://doi.org/10.3390/jcm13030914

AMA Style

Mano M, Nomura A, Sasanabe R. Gender Difference in REM Sleep Behavior Disorder in Japanese Population: Polysomnography and Sleep Questionnaire Study. Journal of Clinical Medicine. 2024; 13(3):914. https://doi.org/10.3390/jcm13030914

Chicago/Turabian Style

Mano, Mamiko, Atsuhiko Nomura, and Ryujiro Sasanabe. 2024. "Gender Difference in REM Sleep Behavior Disorder in Japanese Population: Polysomnography and Sleep Questionnaire Study" Journal of Clinical Medicine 13, no. 3: 914. https://doi.org/10.3390/jcm13030914

APA Style

Mano, M., Nomura, A., & Sasanabe, R. (2024). Gender Difference in REM Sleep Behavior Disorder in Japanese Population: Polysomnography and Sleep Questionnaire Study. Journal of Clinical Medicine, 13(3), 914. https://doi.org/10.3390/jcm13030914

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop